Literature DB >> 29445440

Comparison of Clinical and Radiological Outcome of Carotid Angioplasty and Stenting after Direct Navigation Versus Exchange Methods: A Randomized Clinical Trial.

Mojtaba Rismanchi1,2, Afshin Borhani-Haghighi1,2.   

Abstract

BACKGROUND: The purpose of this study was to compare the frequency of microembolic brain infarcts after direct navigation method versus exchange method in carotid artery stenting and vertebral artery origin angioplasty. METHODS AND MATERIAL: This is a prospective study conducted at Shiraz University of Medical Sciences in southern Iran. Consecutive patients undergoing "carotid angioplasty and stenting" and "vertebral artery origin stenting" were randomly assigned into two groups with "direct navigation method" and "exchange method." Subsequently, postprocedural magnetic resonance imaging (MRI) including diffusion weighted imaging and apparent diffusion coefficient were obtained within the first 24 hours after completion of the procedure.
RESULTS: In total, 89 patients were recruited (67% male, mean age: 72 years). Cases comprised of 38 left internal carotid arteries (ICAs), 38 right ICAs, 6 left vertebral artery origin, and 7 right vertebral artery origin. Forty patients underwent exchange method, while 49 underwent direct navigation method. There was only one clinical stroke that occurred in "exchange method" group. Fifteen patients (37.5%) in exchange group and 23 patients (46.9%) in direct navigation group developed diffusion restricted lesions. In exchange group, 13 patients (32.5%) had at least one diffusion restricted lesion ipsilateral to the target vessel, and three patients (7.5%) had at least one diffusion restricted lesion contralateral to the target vessel. In direct navigation group, these measures were 19 (38.8%) and 9 (18.4%). However, no statistically significant intergroup differences were observed. The only significant difference was bilateral infarct percentile, which was more common in the direct navigation method (0.032).
CONCLUSION: Diffusion restricted lesions were more common in the direct navigation method, both ipsilateral and contralateral to the target vessel, and in both carotid and vertebral artery study subgroups. However, differences were not statistically significant.

Entities:  

Keywords:  Stroke; carotid artery stenting; diffusion restriction; ischemic; microembolic brain infarcts

Year:  2017        PMID: 29445440      PMCID: PMC5805897     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN: 1941-5893


  15 in total

1.  Demographic and Technical Risk Factors of 30-Day Stroke, Myocardial Infarction, and/or Death in Standard- and High-Risk Patients Who Underwent Carotid Angioplasty and Stenting.

Authors:  Afshin Borhani Haghighi; Samaneh Yousefi; Ehsan Bahramali; Safoora Kokabi; Seyed Taghi Heydari; Abdolhamid Shariat; Alireza Nikseresht; Nahid Ashjazadeh; Sadegh Izadi; Peyman Petramfar; Maryam Poursadegh; Abbas Rahimi Jaberi; Sajjad Emami; Hamid Agheli; Reza Nemati; Ehsan Yaghoubi; Mohammad Hosein Abdi; Majid Panahandeh; Moslem Heydari; Anahid Safari; Marziyeh Basir; Salvador Cruz-Flores; Randal Edgell
Journal:  Interv Neurol       Date:  2015-07

2.  A modified technique for carotid cannulation via the transfemoral approach, during angioplasty and stent placement.

Authors:  Kamal Gupta; Mazda Biria; Ali Mortazavi
Journal:  Tex Heart Inst J       Date:  2008

Review 3.  Vertebral artery origin stenosis and its treatment.

Authors:  Afshin Borhani Haghighi; Randall C Edgell; Salvador Cruz-Flores; Osama O Zaidat
Journal:  J Stroke Cerebrovasc Dis       Date:  2011 Jul-Aug       Impact factor: 2.136

4.  Aortic arch and common carotid artery plaques with soft components pose a substantial risk of cerebral embolization during carotid stenting.

Authors:  Péter Szikra; Krisztina Boda; Ferenc Rarosi; Attila Thury; Pál Barzó; Tamás Németh; Erika Vörös
Journal:  Interv Neuroradiol       Date:  2016-02-25       Impact factor: 1.610

5.  Large-vessel stenosis in the patients with ischemic stroke in Iran: Prevalence, pattern, and risk factors.

Authors:  Afshin Borhani-Haghighi; Mehrdad Emami; Amin Sadeghi Vasaksi; Abdolhamid Shariat; Mohammad Amin Banihashemi; Alireza Nikseresht; Nahid Ashjazadeh; Sadegh Izadi; Peyman Petramfar; Maryam Poursadegh; Abbas Rahimi Jaberi; Sajjad Emami; Hamid Agheli; Reza Nemati; Ehsan Yaghoubi; Mohammad Hosein Abdi; Mohammad Mohammadi; Peyman Jafari; Salvador Cruz-Flores; Randal Edgell
Journal:  J Vasc Interv Neurol       Date:  2015-02

6.  Effect of the distal-balloon protection system on microembolization during carotid stenting.

Authors:  N Al-Mubarak; G S Roubin; J J Vitek; S S Iyer; G New; M B Leon
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

7.  Risk factors for cerebral embolization after carotid artery stenting with embolic protection: a diffusion-weighted magnetic resonance imaging study in 837 consecutive patients.

Authors:  Klaudija Bijuklic; Andreas Wandler; Yuriy Varnakov; Thilo Tuebler; Joachim Schofer
Journal:  Circ Cardiovasc Interv       Date:  2013-05-28       Impact factor: 6.546

Review 8.  Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures.

Authors:  Martin Bendszus; Guido Stoll
Journal:  Lancet Neurol       Date:  2006-04       Impact factor: 44.182

9.  Diffusion-weighted lesions after carotid artery stenting are associated with cognitive impairment.

Authors:  Paola Maggio; Claudia Altamura; Doriana Landi; Simone Migliore; Domenico Lupoi; Filomena Moffa; Livia Quintiliani; Stefano Vollaro; Paola Palazzo; Riccardo Altavilla; Patrizio Pasqualetti; Yuri Errante; Carlo Cosimo Quattrocchi; Francesco Tibuzzi; Francesco Passarelli; Roberto Arpesani; Guido di Giambattista; Francesco Rosario Grasso; Giacomo Luppi; Fabrizio Vernieri
Journal:  J Neurol Sci       Date:  2013-03-17       Impact factor: 3.181

10.  ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes.

Authors:  J R Sims; L Rezai Gharai; P W Schaefer; M Vangel; E S Rosenthal; M H Lev; L H Schwamm
Journal:  Neurology       Date:  2009-06-16       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.